Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning

There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. W...

Full description

Saved in:
Bibliographic Details
Published in:Health equity 2022-01, Vol.6 (1), p.55-58
Main Authors: Davis, Alysia, Mendez, Dara D
Format: Article
Language:English
Subjects:
Accountability
Clinical trials
Community
Coronaviruses
COVID-19
COVID-19 vaccines
Decision making
Discrimination
Health disparities
Immunization
Medical research
Oppression
Planning
Public health
Race
Racism
Teams
Transparency
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. We provide an overview and application of remove, repair, remediate, restructure, and provide (R4P), an equity framework, in examining COVID-19 vaccine trial development and related interventions. R4P is an equity framework and tool that applies critical race theory, intersectional, and dimensionality in planning, assessment, and research for creating action to eliminate inequities.
ISSN:2473-1242
2473-1242
DOI:10.1089/heq.2021.0122